Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer
Author:
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.3109/00365519109104621
Reference22 articles.
1. Ovarian tumor antigens
2. The Immunobiology of Ovarian Carcinoma
3. Reactivity of a monoclonal antibody with human ovarian carcinoma.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period;Future Science OA;2017-08
2. Tumor-Associated Trypsin Inhibitor in Patients with Endometrial Cancer;Tumori Journal;2015-08-27
3. Management of a Suspicious Adnexal Mass: A Clinical Practice Guideline;Current Oncology;2012-08-01
4. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers;Clinical Chemistry;2008-12-01
5. Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer;Cancer Epidemiology Biomarkers & Prevention;2005-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3